Sichuan Kelun Pharmaceutical Co., Ltd. (SHE: 002422)
China flag China · Delayed Price · Currency is CNY
32.30
-1.57 (-4.64%)
Oct 11, 2024, 3:04 PM CST

Sichuan Kelun Pharmaceutical Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Oct '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 2018 - 2014
Market Capitalization
51,38542,82937,33526,62127,80333,821
Upgrade
Market Cap Growth
11.25%14.71%40.25%-4.25%-17.79%13.75%
Upgrade
Enterprise Value
53,34547,01945,80736,18938,84143,029
Upgrade
Last Close Price
32.3028.3425.4417.6817.8521.13
Upgrade
PE Ratio
17.6217.8322.1222.6630.7832.21
Upgrade
PS Ratio
2.172.001.961.541.691.92
Upgrade
PB Ratio
2.301.862.211.881.992.43
Upgrade
P/FCF Ratio
20.9412.0016.7414.3428.1338.19
Upgrade
P/OCF Ratio
10.838.0211.949.3512.5315.26
Upgrade
EV/Sales Ratio
2.372.192.412.092.362.44
Upgrade
EV/EBITDA Ratio
9.8510.2613.4113.4516.3515.56
Upgrade
EV/EBIT Ratio
12.7313.8020.2724.3931.8225.39
Upgrade
EV/FCF Ratio
21.7413.1820.5419.4939.2948.58
Upgrade
Debt / Equity Ratio
0.240.310.670.840.880.84
Upgrade
Debt / EBITDA Ratio
1.131.543.284.415.214.20
Upgrade
Debt / FCF Ratio
2.492.005.066.4212.5213.12
Upgrade
Asset Turnover
0.620.610.580.540.520.58
Upgrade
Inventory Turnover
3.352.922.762.342.302.22
Upgrade
Quick Ratio
1.501.321.040.740.860.68
Upgrade
Current Ratio
1.971.831.381.041.200.96
Upgrade
Return on Equity (ROE)
14.78%13.27%10.99%6.17%5.67%7.60%
Upgrade
Return on Assets (ROA)
7.18%6.03%4.30%2.92%2.40%3.48%
Upgrade
Return on Capital (ROIC)
8.89%7.30%5.21%3.54%2.94%4.27%
Upgrade
Earnings Yield
5.68%5.73%4.57%4.14%2.98%2.77%
Upgrade
FCF Yield
4.78%8.33%5.97%6.97%3.56%2.62%
Upgrade
Dividend Yield
1.54%2.82%2.42%2.41%1.79%2.01%
Upgrade
Payout Ratio
50.16%45.87%60.60%90.33%136.49%90.54%
Upgrade
Buyback Yield / Dilution
-1.65%-4.17%-4.91%1.15%-0.05%-0.15%
Upgrade
Total Shareholder Return
-0.12%-1.35%-2.49%3.56%1.73%1.86%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.